Increased expression of all the selected genes except NECTIN4 and SNAI1 showed significant correlation with poor clinical outcomes in patients with serous ovarian cancer, but not with the endometrioid subtype (Table S4). Here, NECTIN4 is linked to ovarian serous adenocarcinoma.